Navigation Links
Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
Date:6/13/2008

Paris, France, Friday 13 June 2008: A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. The chip (called the 'ARTchip') has yielded two clinical-genetic models of RA outcomes, to assist physicians in anticipating likely disease progression and prognosis and thereby guide decisions on the best course of treatment for individual patients.

The DNA microarray chip was developed as a tool to study 71 gene polymorphisms (tiny variations in the DNA that can cause or have a role in RA disease activity) in 45 genes chosen specifically for their presumed role in RA.

Dr Alejandro Balsa, of University Hospital La Paz, Madrid, Spain, who led the study, said: "Prognostic markers, identified through our microarray chip, can be used to predict disease outcomes in RA patients which may help healthcare professionals to choose the best treatment for each patient depending on their level of disease activity."

Predicting Severe Disability

6% and 8% of patients in the study and validation populations had a Health Assessment Questionnaire (HAQ) score of 2 or more indicating severe disability due to RA. The results from the DNA array significantly improved the ability of clinical scores to predict functional impairment.

Results of the study showed that clinical scores in combination with the DNA array had a high level of accuracy when compared in the two independent populations (sensitivity (S): 41%, specificity (Sp): 95% and likelihood ratio (LR): 7.6 in the study group, and S: 21%, Sp: 95% and LR: 4.4 in the validation population).

Predicting Remission

Overall, 6% and 7% of patients in the study and validation groups, respectively fell into the disease remission category. The results from the clinical scores in combination with the DNA
'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Who Knew You Could Learn to Lose Weight by Reading an Enjoyable Novel?
2. OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
3. Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
4. USC researchers identify genetic markers that predict efficacy of novel cancer drug
5. Farmington Hills Plastic Surgeon Uses Novel Procedure: Patients Own Fat From Liposuction for Buttock Enhancement
6. Novel toxin receptor discovered for ulcer-causing stomach pathogen
7. Novel enzyme inhibitor paves way for new cancer drug
8. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
9. Novel mechanisms controlling insulin release and fat deposition discovered
10. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
11. Discovery of a novel mechanism for the development of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...8 /PRNewswire-FirstCall/ - Med-Emerg International...eading providers of health services, is pleased to...ur of the previously announced plan of arrangement...AIM") at a special meeting of MedEmerg,s sharehold... votes cast at the meeting were in favour of the A...
(Date:1/8/2009)...., Jan. 8 Today, the Na...ong with several national leadership organizations...ples of hospice care and protection of the Medicar...ther in sharing this unified message about end-of-...and Palliative Medicine, Hospice and Palliative Nu...
(Date:1/8/2009)...embly Member Tom Torlakson Introduces AB 89 , ,.../ -- Today, Lung Cancer Alliance-California (LCA...son (D-11th District) for his continued leadership...lung cancer research. For the third consecutive y...rch is being considered in the California Legislat...
(Date:1/8/2009)...ered bad cholesterol more effectively than Zocor ,...After nearly a year of review, U.S. health officia... use of the controversial cholesterol-lowering dru...ion said there was no significant difference in ca...orin and patients taking the drug Zocor. , But,...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
...e National Health Services (NHS) patients, current...ttended to following the Government report that wo...ials had stated earlier that the maximum waiting p... they were to be admitted to a hospital by the end...
...nada: There is good news for patients afflicted b...aster, bone marrow donees and several others who a...e, invented by a researcher // at the University o...BR), is capable of scaling down the loss of transf...
...cording to scientist a new computer model has been...pidemic of malaria. The intensity whether it would...it occurs. // This would give ample time for preve...one in advance. The control of malaria is a top p...
...ientists in northern Tasmania have revealed that t...ng tumor disease affecting Tasmanian devils. // Th...also be transferred when the animals are mating, t...nne-Maree Pearse from the state's Primary Industri...
Other Medicine News:Health News:Quality Platelets and Improved Blood Availability No Longer a Pipe Dream 2Health News:Prediction of malaria epidemics possible! 2
(Date:1/8/2009)..., UT Southwestern to Identify and Validate Novel...ing with Innovative Gene Expression Platform , ,...- WaferGen Biosystems, Inc. (OTC Bulletin Board: W... expression, genotyping, cell biology and stem cel... a research collaboration with the University of ...
(Date:1/7/2009)..., INDIANAPOLIS, Jan. 7 /PRNewswire-FirstCall...ed today that it received a complete response lett...A) for olanzapine long-acting,injection (LAI) for...in,adults. Lilly is continuing to work with the a... The FDA does not require any additional clinical ...
(Date:1/7/2009)..., First of Several Products in Development Based...ogy to Stimulate Natural BioRegeneration; FDA Fili...TOWN, N.J., Jan. 7 Ost...erging field of biologic products for regenerative...pivotal clinical trial for its DuraTech(TM) BioReg...
(Date:1/6/2009)..., Proves significance of AHCC for maintaining a ...6 A recently published study in N...rs at Kansai Medical University in Osaka, Japan ha...nd) enhances immune function by increasing the num...f the immune system responsible for presenting for...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Online Counseling and Life Coaching Practice Launches New Website 24418 1Online Counseling and Life Coaching Practice Launches New Website 24418 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 1NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 3NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 4NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 5NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 6NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 7NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 8BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 1BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 2BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 3Experts to provide peek of Smithsonian soils exhibit 4208 1
... of cancer returning,after surgery for Kit-positiv...OVER, N.J., April 12, 2007 /PRNewswire/ -- Investi...sylate)* tablets to,patients receiving placebo in ...erim analysis showed participants with Kit-positiv...evec following,surgery were significantly less lik...
...,/PRNewswire-FirstCall/ -- Data analyses from the ...m ever undertaken in the renal,anemia arena provid...tional anemia therapy MIRCERA(TM) for the treatmen...isease (CKD) in,patients on dialysis and not on di...National Kidney Foundation 2007 Spring Clinical,Me...
Other Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4
... knee prosthesis stems from many years of experien... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern... a minimum. The inherent design of the components,...
... "Consensus Concept" approach to design by combini...perience of a Scientific Advisory Board. The resul...tate-of-the-art features. Consensus Knee implants ...bility and allow near normal kinematics. The compo...
The major innovations in posterior stabilized (PS) knee design.
The GENESIS II* Total Knee System will define the state of knee implants.
Medicine Products: